Purus Wealth Management LLC cut its holdings in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 1.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 86,655 shares of the company’s stock after selling 1,070 shares during the period. ARK Genomic Revolution ETF makes up approximately 0.9% of Purus Wealth Management LLC’s portfolio, making the stock its 28th biggest position. Purus Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $2,035,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Principal Securities Inc. bought a new position in shares of ARK Genomic Revolution ETF in the 4th quarter worth about $32,000. Tidemark LLC bought a new position in shares of ARK Genomic Revolution ETF in the 4th quarter worth about $48,000. Chris Bulman Inc bought a new position in shares of ARK Genomic Revolution ETF in the 2nd quarter worth about $36,000. EverSource Wealth Advisors LLC bought a new position in shares of ARK Genomic Revolution ETF in the 1st quarter worth about $49,000. Finally, Larson Financial Group LLC raised its position in shares of ARK Genomic Revolution ETF by 4,576.1% in the 2nd quarter. Larson Financial Group LLC now owns 3,320 shares of the company’s stock worth $78,000 after acquiring an additional 3,249 shares in the last quarter.
ARK Genomic Revolution ETF Price Performance
ARKG stock opened at $26.29 on Wednesday. The stock has a fifty day simple moving average of $25.64 and a 200-day simple moving average of $25.88.
ARK Genomic Revolution ETF Company Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Stories
- Five stocks we like better than ARK Genomic Revolution ETF
- Why Invest in High-Yield Dividend Stocks?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What is a Stock Market Index and How Do You Use Them?
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
